©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3442-3448
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3442
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3442
Table 2 Partial laboratory test results from last reexamination (July 2, 2020)
| Serum marker (unit) | Actual value | Reference range |
| Alanine aminotransferase (U/L) | 18 | 1-52 |
| Aspartate aminotransferase (U/L) | 33 | 1-40 |
| HBsAg (IU/mL) | < 0.03 | < 0.05 |
| HBsAb (mIU/mL) | > 1000 | 0.0-10.00 |
| HBeAg (PEIU/mL) | < 0.01 | 0.00-0.11 |
| HBeAb (PEIU/mL) | < 0.1 | > 1.10 |
| HBcAb (IU/mL) | < 0.1 | > 1.10 |
| HBV DNA (IU/mL) | < 30 | < 30 |
| White blood cell (109/L) | 5.95 | 4.0-10.0 |
| Neutrophil (109/L) | 2.66 | 2.00-7.00 |
| Red blood cell (1012/L) | 4.16 | 3.50-5.50 |
| Platelet (109/L) | 306.0 | 100.0-300.0 |
- Citation: Zhang YT, Liu J, Pan XB, Gao YD, Hu YF, Lin L, Cheng HJ, Chen GY. Successful treatment of infantile hepatitis B with lamivudine: A case report. World J Clin Cases 2021; 9(14): 3442-3448
- URL: https://www.wjgnet.com/2307-8960/full/v9/i14/3442.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i14.3442